Question 1

What specific symptoms of my psoriatic arthritis would this trial address?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis clinical trial (NCT01989468). Contact the study team or your healthcare provider for specific answers.

Question 2

How does secukinumab compare to other treatments I am currently considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis clinical trial (NCT01989468). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis clinical trial (NCT01989468). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis clinical trial (NCT01989468). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis clinical trial (NCT01989468). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis clinical trial (NCT01989468). Contact the study team or your healthcare provider for specific answers.

What this study is about